Saturday , 5 October 2024
Home Senate testimony

Senate testimony

Lars Fruergaard Jørgensen
Healthcare

Novo Nordisk CEO Defends Ozempic Pricing in Senate Hearing

In a recent Senate testimony, Lars Jørgensen, the CEO of Novo Nordisk, defended the pricing of Ozempic, the company’s widely used medication for...